drugset / Trial / NCT00017043

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

NCT00017043

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have metastatic stomach cancer previously treated with chemotherapy.

Timeline

Start
2001-02
Primary completion
2003-01
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous